Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
暂无分享,去创建一个
P M Matthews | G S Francis | P. Matthews | D. Arnold | N. De Stefano | J. Antel | M. Tartaglia | S. Narayanan | N. Stefano | G. Francis | D L Arnold | S Narayanan | N De Stefano | J P Antel | R. Arnaoutelis | R Arnaoutelis | M C Tartaglia | N. de Stefano | J. Antel | Paul M. Matthews | Sridar Narayanan | Rozie Arnaoutelis
[1] A. Członkowska,et al. [Axonal degeneration in the pathogenesis of multiple sclerosis]. , 2002, Neurologia i neurochirurgia polska.
[2] S G Waxman,et al. Multiple sclerosis as a neuronal disease. , 2005, Archives of neurology.
[3] G. B. Pike,et al. Relating axonal injury to functional recovery in MS , 2000, Neurology.
[4] R I Grossman,et al. Total brain N-acetylaspartate , 2000, Neurology.
[5] K. Bhakoo,et al. In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes , 2000, Journal of neurochemistry.
[6] P M Matthews,et al. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. , 2000, Archives of neurology.
[7] G J Barker,et al. Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? , 1999, Journal of neurology, neurosurgery, and psychiatry.
[8] R. Herndon,et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis , 1999, Neurology.
[9] F Barkhof,et al. Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.
[10] B D Trapp,et al. Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.
[11] Max S. Cynader,et al. Axonal cytoskeleton changes in experimental optic neuritis , 1999, Brain Research.
[12] R. Tarducci,et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. , 1999, Brain : a journal of neurology.
[13] R. Rudick,et al. Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability , 1999 .
[14] B. Stankoff,et al. Eliprodil stimulates CNS myelination , 1999, Neurology.
[15] Kenneth J. Smith,et al. Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.
[16] C. Heldin,et al. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. , 1998, Brain : a journal of neurology.
[17] Robin Franklin,et al. Axon loss in multiple sclerosis , 1998, The Lancet.
[18] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[19] G. Barker,et al. Spinal cord atrophy and disability in MS , 1998, Neurology.
[20] N. Losseff,et al. Measures of brain and spinal cord atrophy in multiple sclerosis. , 1998, Journal of neurology, neurosurgery, and psychiatry.
[21] W. Brück,et al. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions , 1998, Multiple sclerosis.
[22] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[23] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[24] G. Wolswijk. Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells , 1998, The Journal of Neuroscience.
[25] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[26] P. Matthews,et al. Putting Magnetic Resonance Spectroscopy Studies in Context: Axonal Damage and Disability in Multiple Sclerosis , 1998, Seminars in neurology.
[27] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[28] A. Compston. Future Options for Therapies to Limit Damage and Enhance Recovery , 1998, Seminars in neurology.
[29] G. Barker,et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.
[30] S. Waxman,et al. Distribution of sodium channels in chronically demyelinated spinal cord axons: immunoultrastructural localization and electrophysiological observations. Brain Research 544 (1991) 59-70. , 1997, Brain research.
[31] M. Rovaris,et al. A Longitudinal Magnetic Resonance Imaging Study of the Cervical Cord in Multiple Sclerosis , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[32] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[33] R. Barker,et al. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion , 1997, Journal of Neurology.
[34] S. Waxman. Molecular remodeling of neurons in multiple sclerosis: what we know, and what we must ask about brain plasticity in demyelinating diseases. , 1997, Advances in neurology.
[35] Jullie W Pan,et al. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T , 1996, Magnetic resonance in medicine.
[36] P. Matthews,et al. Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.
[37] A. Thompson,et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. , 1995, Brain : a journal of neurology.
[38] P. Matthews,et al. Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.
[39] Jia Newcombe,et al. High Resolution Proton NMR Spectroscopy of Multiple Sclerosis Lesions , 1995, Journal of neurochemistry.
[40] G. Fein,et al. Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging , 1994, Annals of neurology.
[41] W. Mcdonald. RACHELLE FISHMAN-MATTHEW MOORE LECTURE: The Pathological and Clinical Dynamics of Multiple Sclerosis , 1994, Journal of neuropathology and experimental neurology.
[42] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] R de Beer,et al. Application of time‐domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets , 1992, NMR in biomedicine.
[44] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[45] M. Lazdunski,et al. Increase of sodium channels in demyelinated lesions of multiple sclerosis , 1991, Brain Research.
[46] W. Mcdonald,et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.
[47] S. Waxman,et al. Distribution of sodium channels in chronically demyelinated spinal cord axons: immuno-ultrastructural localization and electrophysiological observations , 1991, Brain Research.
[48] J. Neale,et al. Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.
[49] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[50] William H. Oldendorf,et al. N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.
[51] D Matthaei,et al. 1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.
[52] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[53] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.